Answers are grounded in this paper and cite their sources.
Preoperative serum albumin is an appealing biomarker because it is inexpensive, routinely measured, and integrates nutritional, inflammatory, and comorbidity burden. In this single-center cohort of 1774 adults undergoing nephrectomy for nonmetastatic renal cell carcinoma between 2000 and 2025, Lahiji et al1 show that hypoalbuminemia (<3.5 g/dL) in approximately 15% of patients is independently associated with both prolonged hospital stay (≥7 days; adjusted odds ratio 1.65) and 90-day readmission (adjusted odds ratio 1.61), with a linear relationship between lower albumin and longer length of stay after multivariable adjustment. Clinically, these data support using albumin as a simple flag for vulnerable renal cell carcinoma patients who may benefit from preoperative nutritional assessment, prehabilitation, and more intensive discharge planning. The results complement prior evidence that low albumin predicts worse survival in renal cell carcinoma and adverse outcomes across surgical oncology populations and are consistent with contemporary nutrition guidelines that advocate proactive identification and optimization of malnourished patients before major surgery.2,3 For teams implementing enhanced recovery pathways, integrating albumin into preoperative huddles or risk calculators could help allocate resources such as early dietician input, closer postoperative monitoring, and structured early follow-up after discharge. At the same time, several aspects of the study warrant caution before adopting albumin as a stand-alone triage tool. The retrospective design spanning 25 years, evolving perioperative care, incomplete capture of readmissions outside the health system, and absence of key variables such as baseline kidney function, inflammatory markers, operative time, and blood loss leave room for residual confounding. Albumin is nonspecific and may primarily mark broader frailty or systemic disease rather than a modifiable causal pathway. Prospective, multi-institutional studies, including albumin within multidimensional frailty and nutrition assessments and testing targeted interventions in hypoalbuminemic patients, are now needed to determine whether altering preoperative care based on albumin can truly shorten length of stay and reduce readmissions.
No takes yet. Share an insight, caveat, or question.
Pavan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: